4-(溴甲基)萘-1-羧酸 | 30236-02-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 中文名称: 4-(溴甲基)萘-1-羧酸
• 中文别名: 4-溴甲基-萘-1-羧酸
• 英文名称: 4-(bromomethyl)-1-naphthoic acid
• 英文别名: 4-(bromomethyl)naphthalene-1-carboxylic Acid
• CAS: 30236-02-3
• 化学式: C₁₂H₉BrO₂
• 分子量: 265.106
• InChiKey: FPUUDRJMMXKEMP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.08
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 海关编码：
  2916399090

反应信息

• 作为反应物：
  描述：

  4-(溴甲基)萘-1-羧酸 在 硫酸 作用下， 反应 0.5h， 生成 4-羟甲基-1-萘甲酸甲酯
  参考文献：
  名称：

  Optimization of Alkylidene Hydrazide Based Human Glucagon Receptor Antagonists. Discovery of the Highly Potent and Orally Available 3-Cyano-4-hydroxybenzoic Acid [1-(2,3,5,6-Tetramethylbenzyl)-1H-indol-4-ylmethylene]hydrazide

  摘要：

  Highly potent human glucagon receptor (hGluR) antagonists have been prepared employing both medicinal chemistry and targeted libraries based on modification of the core (proximal) dimethoxyphenyl group, the benzyl ether linkage, as well as the (distal) benzylic aryl group of the lead 2, 3-eyano-4-hydroxybenzoic acid (3,5-dimethoxy-4-isopropylbenzyloxybenzylidene)hydrazide. Electron-rich proximal aryl moieties such as mono- and dimethoxy benzenes, naphthalenes, and indoles were found to be active. The SAR was found to be quite insensitive regarding the linkage to the distal aryl group, since long and short as well as polar and apolar linkers gave highly potent compounds. The presence of a distal aryl group was not crucial for obtaining high binding affinity to the hGluR. In many cases, however, the affinity could be further optimized with substituted distal aryl groups. Representative compounds have been tested for in vitro metabolism, and structure-metabolism relationships are described. These efforts lead to the discovery of 74, NNC 25-2504, 3-cyano-4-hydroxybenzoic acid [1-(2,3,5,6-tetramethylbenzyl)-1H-indol-4-ylmethylenelhydrazide, with low in vitro metabolic turnover. 74 was a highly potent noncompetitive antagonist of the human glucagon receptor (IC50 = 2.3 nM, K-B = 760 pM) and of the isolated rat receptor IC50 = 430 pM, K-B = 380 pM). Glucagon-stimulated glucose production from isolated primary rat hepatocytes was inhibited competitively by 74 (K-i = 14 nM). This compound was orally available in dogs (F-po = 15%) and was active in a glucagon-challenged rat model of hyperglucagonemia and hyperglycemia.

  DOI：

  10.1021/jm0208572
• 作为产物：
  描述：

  4-甲基-1-萘乙酮 在 sodium hypochlorite 、 N-溴代丁二酰亚胺(NBS) 、 氢溴酸 作用下， 以 甲醇 、 四氯化碳 、 水 、 苯 为溶剂， 反应 90.5h， 生成 4-(溴甲基)萘-1-羧酸
  参考文献：
  名称：

  Dixon, Elisabeth A.; Fischer, Alfred; Robinson, Frank P., Canadian Journal of Chemistry, 1981, vol. 59, p. 2629 - 2641

  摘要：

  DOI：

文献信息

• [EN] THERAPEUTIC COMPOUNDS: PYRIDINE AS SCAFFOLD<br/>[FR] COMPOSES THERAPEUTIQUES DANS LESQUELS LA PYRIDINE EST UTILISEE COMME SQUELETTE
  申请人：ASTRAZENECA AB

  公开号：WO2005115986A1

  公开（公告）日：2005-12-08

  Compounds of formulas I, IA, and IB or IC or pharmaceutically acceptable salts thereof: wherein A, A1, A2, A3, A4, R2, R3, R4 and n are as defined in the specifications well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.

  其中A、A1、A2、A3、A4、R2、R3、R4和n的化合物的公式I、IA和IB或IC或其药学上可接受的盐：其中A、A1、A2、A3、A4、R2、R3、R4和n的定义如规范中所述，以及包括这些化合物的盐和药物组合物已经准备好。它们在治疗中很有用，特别是在疼痛管理中。
• Glucagon antagonists/inverse agonists
  申请人：Novo Nordisk A/S

  公开号：US06613942B1

  公开（公告）日：2003-09-02

  Non-peptide compounds comprising a central hydrazide motif and methods for the synthesis thereof are disclosed. The compounds act to antagonize the action of the glucagon peptide hormone.

  本发明公开了包含中央腙基结构的非肽化合物及其合成方法。这些化合物具有拮抗胰高血糖素肽激素作用的作用。
• [EN] INSECTICIDAL ARYLPYRROLINES<br/>[FR] ARYLPYRROLINES INSECTICIDÉS
  申请人：BAYER CROPSCIENCE AG

  公开号：WO2009097992A1

  公开（公告）日：2009-08-13

  The invention relates to novel arylpyrroline compounds of formula (I) which have excellent insecticidal activity and which can thus be used as insecticides.

  该发明涉及具有优异杀虫活性的新型芳基吡咯烯化合物（I）的公式，因此可用作杀虫剂。
• Pd-catalyzed allylative dearomatisation using Grignard reagents
  作者：Cosimo Boldrini、Syuzanna R. Harutyunyan

  DOI：10.1039/d1cc05609c

  日期：——

  naphthyl halides is shown to be feasible by employing Grignard reagents. The high reactivity of the nucleophile allows for fast reactions and low catalyst loading, while a plethora of successfully substituted compounds illustrate the broad scope. Five membered heteroaromatic compounds are also demonstrated to be reactive under similar conditions.

  通过使用格氏试剂，钯催化的萘基卤化物的烯丙基化脱芳构化被证明是可行的。亲核试剂的高反应活性允许快速反应和低催化剂负载，而大量成功取代的化合物说明了广泛的范围。五元杂芳族化合物也被证明在类似条件下具有反应性。
• 一种制备噁唑啉杀虫剂阿福拉纳中间体的方法
  申请人：丽珠集团新北江制药股份有限公司

  公开号：CN112679338A

  公开（公告）日：2021-04-20

  本发明公开了一种制备噁唑啉杀虫剂阿福拉纳中间体的方法，该中间体为4‑甲酰基‑萘‑1‑羧酸，与US6613942B1的合成路线相比。本发明一些实例的方法，通过探索，将反应步骤由3步缩短到1步，不仅可以得到纯度合格的噁唑啉杀虫剂阿福拉纳中间体产品。在简化了中间体控制步骤的同时，提高了产品收率，更加易于工业化生产。